Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection

International Immunology

Volumn 16, Issue 8, 2004, Pages 1125-1131

  Zafirova, Yana ^a   Yordanov, Martin ^b   Kalfin, Reni ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

^b INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

Anti infectious resistance; Collagen induced arthriitis; Cytokines

Indexed keywords

COLLAGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; HOST RESISTANCE; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPLEEN CELL; SURVIVAL RATE; TH2 CELL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CANDIDA ALBICANS; CANDIDIASIS; COLLAGEN; CYTOKINES; IMMUNOGLOBULIN G; KIDNEY; MICE; TH2 CELLS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 4344621646     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh114     Document Type: Article

References (29)

1. Williams, R. O., Marinova-Mutafchieva, L., Feldmann, M. and Maini, R. N. 2000. Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy. J. Immunol. 165:7240.
2. Palmer, G., Talabot-Ayer, D., Szalay-Quinodoz, Maret, M., Arend, W. P. and Gabay, C. 2003. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis. Eur. J. Immunol. 33:434.
3. Brennan, F. M., Chantry, D., Jackson, A., Maini, R. and Feldmann, M. 1989. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244.
4. Feldmann, M., Brennan, F. M. and Maini, R. N. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
5. Fox, D. A. 1997. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 40:598.
6. Gerli, R., Bistoni, O., Russano, A., Fiorucci, S., Borgato, L., Cesarotti, M. E. and Lunardi, C. 2002. In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin. Exp. Immunol. 129:549.
7. Mauri, C., Feldmann, M. and Williams, R. O. 2003. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. Arthritis Rheum. 48:839.
8. Delgado, M., Leceta, J., Gomariz, R. P. and Ganea, D. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. J. Immunol. 163:3629.
9. Ottaway, C. A. 1987. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells. Immunology 62:291.
10. Delgado, M., Abad, C., Martinez, C., Leceta, J. and Gomariz, R. P. 2001. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7:563.
11. Delgado, M., Abad, C., Martinez, C., Juarranz, M. G., Arranz, A., Gomariz, R. P. and Leceta, J. 2002. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med. 80:16.
12. Nolting, S., Stanescu-Siegmund, A. and Schwantes, P. A. 1998. Candida and the gastrointestinal tract. A medical-research evaluation. Fortschr. Med. 116:22.
13. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462.
14. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Puccetti, P. and Bistoni, F. 1993. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150:925.
15. Cenci, E., Mencacci, A., Del Sero, G., Bistoni, F. and Romani, L. 1997. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. J. Infect. Dis. 176:217.
16. Romani, L., Cenci, E., Menacci, A., Bistoni, F. and Puccetti, P. 1995. T helper cell dichotomy to Candida albicans: implications for pathology, therapy and vaccine design. Immunol. Res. 14:148.
17. Romani, L., Puccetti, P. and Bistoni, F. 1996. Biological role of Th cell subsets in candidiasis. Chem. Immunol. 63:115.
18. Ivanovska, N., Yordanov, M. and Raykovska, V. 2003. Single immunization of newborn mice with hetrologous type-II collagen induces arthritic disease. Autoimmunity 36:205.
19. Luross, J. A. and Williams, N. A. 2001. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 103:407.
20. Romani, L., Mencacci, A., Tonnetti, L., Spaccapelo, R., Cenci, E., Wolf, S., Puccetti, P. and Bistoni, F. 1994. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909.
21. Puccetti, P., Romani, L. and Bistoni, F 1995. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 3:237.
22. Lavigne, L. M., Schopf, L. R., Chung, C. L., Maylor, R. and Sypek, J. P. 1998. The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection. J. Immunol. 160:284.
23. Mencacci, A., Cenci, E., Del Sero, G., Fe d'Ostiani, C., Mosci, P., Montagnoli, C., Bacci, A., Bistoni, F., Quesniaux, V. F., Ryffel, B. and Romani, L. 1998. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. Int. Immunol. 10:37.
24. Qian, Q. and Cutler, J. E. 1997. Gamma interferon is not essential in host defense against disseminated candidiasis in mice. Infect. Immun. 65:1748.
25. Cenci, E., Mencacci, A., Del Sero, G., d'Ostiani, C. F., Mosci, P., Bacci, A., Montagnoli, C., Kopf, M. and Romani, L. 1998. IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. J. Immunol. 161:3543.
26. Szabo, S. J., Dighe, A. S., Gubler, U. and Murphy, K. M. 1997. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
27. Mencacci, A., Cenci, E., Del Sero, G., Fe d'Ostiani, C., Mosci, P., Trinchieri, G., Adorini, L. and Romani, L. 1998. IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J. Immunol. 161:6228.
28. Mencacci, A., Cenci, E., Bistoni, F., Bacci, A., Del Sero, G., Montagnoli, C., Fe d'Ostiani, C. and Romani, L. 1998. Specific and non-specific immunity to Candida albicans: a lesson from genetically modified animals. Res. Immunol. 149:352.
29. Mencacci, A., Del Sero, G., Cenci, E., d'Ostiani, C. F., Bacci, A., Montagnoli, C., Kopf, M. and Romani, L. 1998. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J. Exp. Med. 187:307.